CHIMERIC MHC PROTEIN AND OLIGOMER THEREOF

(19)

(11)

EP 1 530 592 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	25.03.2009 Bulletin 2009/13

(45)	Mention of the grant of the patent:
	17.12.2008 Bulletin 2008/51

(21)	Application number: 03792325.7

(22)	Date of filing: 14.08.2003

(51)

International Patent Classification (IPC):

C07K 14/74^(2006.01)
C12N 15/62^(2006.01)
A61K 38/17^(2006.01)

C07K 14/78^(2006.01)
C12N 15/12^(2006.01)
G01N 33/68^(2006.01)

(86)	International application number:
	PCT/EP2003/009056

(87)	International publication number:
	WO 2004/018520 (04.03.2004 Gazette 2004/10)

(54)	CHIMERIC MHC PROTEIN AND OLIGOMER THEREOF CHIMÄRES MHC-PROTEIN UND OLIGOMER DAVON PROTEINE CHIMERIQUE MHC ET SON OLIGOMERE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(30)

Priority:

21.08.2002 GB 0219459

(43)	Date of publication of application:
	18.05.2005 Bulletin 2005/20

(73)	Proprietor: ProImmune Limited
	Oxford OX4 4GA (GB)

(72)	Inventors:
	SCHWABE, Nikolai, Franz, Gregor Oxford OX2 6BP (GB) CHENG-CHOO TAN, Linda Oxford OX2 6BP (GB) NAPPER, Catherine, Elizabeth Coggs, Whitney OX28 3UD (GB) FRY, Jeremy, William Nuneham Courtney OX44 9PQ (GB) PANG, Susan Lincoln LN2 2ES (GB) SPOONER, Rachel, Kate Oxford OX3 0RU (GB)

(74)	Representative: Vossius & Partner
	Siebertstraße 4 81675 München 81675 München (DE)

(56)

References cited: :

WO-A-98/06749
WO-A-02/055992

WO-A-99/42597
US-A1- 2002 082 411

MÜLLER K M ET AL: "Protein fusions to coiled-coil domains." METHODS IN ENZYMOLOGY. UNITED STATES 2000, vol. 328, 2000, pages 261-282, XP008025980 ISSN: 0076-6879
HOLLER N ET AL: "Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors" JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 237, no. 1-2, April 2000 (2000-04), pages 159-173, XP004192503 ISSN: 0022-1759 cited in the application
TERSKIKH ALEXEY V ET AL: "Peptabody: A new type of high avidity binding protein" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 94, no. 5, 1997, pages 1663-1668, XP002147182 ISSN: 0027-8424

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).